Antiepileptic drugs and neuropathic pain;Fármacos antiepilépticos y dolor neuropático

Revista de Neurologia

Volumn 32, Issue 4, 2001, Pages 345-350

  Martinez Salio A ^a   Porta Etessam, J ^a   Berbel Garcia A ^a   Garcia Morales I ^a   De la Pena Mayor P ^a   Vicente Fatela, L ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

Anticonvulsant drugs; GABA; Neuropathic pain; Pathophysiology; Sodium channels; Treatment

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLONAZEPAM; FELBAMATE; GABAPENTIN; LAMOTRIGINE; PHENYTOIN; SODIUM CHANNEL; TIAGABINE; TOPIRAMATE; VALPROIC ACID; VIGABATRIN;

DRUG RESPONSE; HUMAN; NERVE CONDUCTION; NEUROPATHIC PAIN; PAIN; PATHOPHYSIOLOGY; REVIEW;

EID: 0035895445     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.3204.2000460     Document Type: Review

References (94)

1. Prevalence of chronic benign pain disorder among adults: A review of the literature
2. Neuropathic pain: Aetiology, symptoms, mechanisms, and management
3. The neurobiology of pain
4. Efficacy of pharmacological treatments of neuropathic pain: An update and effect related to mechanism of drug action
5. How do drugs relieve neurogenic pain?
6. Neuropathic pain of peripheral origin: Advances in pharmacologic treatment
7. Anticonvulsivant drugs for management of pain: A systematic review
8. A critical review of controlled clinical trials for peripheral neuropathic pain and complex regional pain syndromes
9. Cures hemeuses de névralgies faciales essentielles par le diphenthydantoinate de soude
10. The treatment of shooting pain
11. Trigeminal neuralgia
12. Intravenous infusion of phenytoin relieves neuropathic pain: A randomised, double-blinded, placebo-controlled, crossover study
13. Intravenous phenytoin in the management of crescendo pelvic cancer-related pain
14. A controlled therapeutic study of the irritable-bowel syndrome
15. Double blind study of the effects of diphenylhydantoin sodium on diabetic neuropathy
16. Phenytoin in the treatment of diabetic symmetrical polyneuropathy
17. Clinical trial of carbamazepine in trigeminal neuralgia
18. Carbamazepine in treatment of neuralgia. Use of side elects
19. A four-year double blind study of tegretol in facial pain
20. Glossopharyngeal neuralgia: A study of six cases
21. Aetiology of migraine and prevention with carbamazepine: Results of a double-blind, crossover study
22. Cluster-tic síndrome
23. Chronic Paroxysmal Hemicrania-Tic Síndrome
24. SUNCT syndrome. Trials of drugs and anaesthetic blockades
25. Symptomatic treatment of peripheral diabetic neuropathy with carbamazepine: Double-blind crossover study
26. Carbamazepine in uremic neuropathy
27. Carbamazepine for amyloid neuropathy
28. Carbamazepine for pain management in Guillain-Barré syndrome patients in the intensive care unit
29. Central post-stroke pain- a controlled trial of amitriptyline and carbamazepine
30. Central nervous pain in patients with spinal cord injury. Medical and surgical treatment
31. Problems of symptomatic therapy in multiple sclerosis
32. Oxcarbamazepine: A new drug in the management of intractable trigeminal neuralgia
33. Sodium valproate in the prophylactic treatment of migraine: A double-blind study versus placebo
34. Central analgesic effect of valproate in patients with epilepsy
35. Valproate for treatment of chronic central pain after spinal cord injury. A double-blind crossover study
36. Positive response to oral dilvaproex sodium in patients with spasticity and pain
37. Sodium valproate in the treatment of cluster headache: An open clinical trial
38. The medical and surgical management of trigeminal neuralgia
39. Pain relief in diabetic neuropathy: The effectiveness of imipramine and related drugs
40. Clonazepam in migraine prophylaxis
41. Administration of clonazepam in the treatment of TMD and associated myofacial pain in double-blind pilot study
42. A possible therapeutic solution for stomatodynia (burning mouth syndrome)
43. Possible analgesic effect of vigabatrin in animal experimental chronic neuropathic pain
44. Vigabatrin as spasmolytic drug
45. Improvement of stiff-man syndrome with vigabatrin
46. A prospective audit of the use of lamotrigine in 300 chronic pain patients
47. Lamotrigine in refractory trigeminal neuralgia: Results from a double-blind placebo controlled crossover trial
48. Lamotrigine control of trigeminal neuralgia: An expanded study
49. Lamotrigine can remove the pain associated with painful diabetic neuropathy
50. Lamotrigine in the treatment of painful diabetic neuropathy
51. Efficacy of lamotrigine on sensory symptoms and pain in peripheral neuropathies
52. Lamotrigine control of central pain
53. Lamotrigine can reduce neurogenic pain associated with multiple sclerosis
54. The use of lamotrigine in neuropathic pain
55. Lamotrigine reduces total postoperative analgesic requirement: A randomised double-blind, placebo-controlled pilot study
56. 200 Mg daily of lamotrigine has no analgesic effect in neuropathic pain: A randomised, double-blind, placebo controlled trial
57. Mechanisms of action of gabapentin
58. Gabapentin for the treatment of painful neuropathy in patients with diabetes mellitus: A randomised controlled trial
59. Gabapentin monotherapy for the symptomatic treatment of painful neuropathy: A multicenter, double-blind, placebo-controlled trial in patients with diabetes mellitus
60. Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain
61. Gabapentin for the treatment of postherpetic neuralgia: A randomised controlled trial
62. Gabapentin for idiopathic trigeminal neuralgia: Report of two cases
63. Efecto de la gabapentina en la alodinia bucofacial. Correlación experimental de neuralgia trigeminal
64. Respuesta clínica de la neuralgia del glosofaríngeo a la gabapentina
65. Pain in Guillain-Barré syndrome
66. Open label gabapentin treatment for pain in multiple sclerosis
67. Amelioration of refractory dysesthetic limb pain in multiple sclerosis by gabapentin
68. An open-label trial of gabapentin treatment of paroxysmal symptoms in multiple sclerosis patients
69. Gabapentin as an adjuvant to opioid analgesia for neuropathic cancer pain
70. Reflex sympathetic dystrophy treated with gabapentin
71. Gabapentin therapy for vulvodynia
72. Erytromelalgia pain managed with gabapentin
73. Nonepileptic uses of gabapentin
74. The effect of gabapentin on neuropathic pain
75. Tratamiento del dolor neuropático con gabapentina
76. 3-Substituted GABA analogs with central nervous system activity: A review
77. N-methyl-D-aspartate (NMDA) receptors, mu and kappa opioid tolerance, and perspectives on new analgesic drug development
78. Felbamate relieved trigeminal neuralgia
79. Hemifacial spasm: Successful treatment with felbamate
80. Topiramate-treated cluster headache
81. Basic mechanisms of gabitril (tiagabine) and future potential developments
82. Tiagabine antinociception in rodents depends on GABA (B) receptor activation: Parallel antinociception testing and medial thalamus GABA microdyalisis
83. Overview of neuropathic pain syndromes
84. Mechanism of pain in peripheral neuropathy
85. Sodium channel accumulation in humans with painful neuromas
86. Carbamazepine inhibits spontaneous activity in experimental neuromas
87. Phenytoin suppresses spontaneous extopic discharge in rat sciatic nerve neuromas
88. Spinal pain mechanisms
89. The effect of subarachnoid gabapentin on tactile-evoked allodynia in a surgically-induced neuropathic pain model in the rat
90. Effects of gabapentin on the different components of peripheral and central neuropathic pain syndromes: A pilot study
91. Paraesthesia from ectopic impulse generation in human sensory nerves